Thursday, November 1, 2012

Advanced Cell Diagnostics lines up $12M Series B round

Diagnostic test developer Advanced Cell Diagnostics Inc. completed a $12 million Series B financing, led by New Leaf Venture Partners.
The Hayward company, which developed its RNAscope technology to detect and quantify RNA biomarkers, said existing investor Morningside Ventures also participated in the round.

No comments:

Post a Comment